246 related articles for article (PubMed ID: 29729196)
1. Potential Clinical Targets in Hepatopulmonary Syndrome: Lessons From Experimental Models.
Raevens S; Fallon MB
Hepatology; 2018 Nov; 68(5):2016-2028. PubMed ID: 29729196
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
Zhang J; Luo B; Tang L; Wang Y; Stockard CR; Kadish I; Van Groen T; Grizzle WE; Ponnazhagan S; Fallon MB
Gastroenterology; 2009 Mar; 136(3):1070-80. PubMed ID: 19109954
[TBL] [Abstract][Full Text] [Related]
3. Hepatopulmonary syndrome: update on pathogenesis and clinical features.
Zhang J; Fallon MB
Nat Rev Gastroenterol Hepatol; 2012 Sep; 9(9):539-49. PubMed ID: 22751459
[TBL] [Abstract][Full Text] [Related]
4. Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice.
Raevens S; Geerts A; Paridaens A; Lefere S; Verhelst X; Hoorens A; Van Dorpe J; Maes T; Bracke KR; Casteleyn C; Jonckx B; Horvatits T; Fuhrmann V; Van Vlierberghe H; Van Steenkiste C; Devisscher L; Colle I
Hepatology; 2018 Aug; 68(2):634-651. PubMed ID: 29023811
[TBL] [Abstract][Full Text] [Related]
5. Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome.
Wu W; Zhang J; Yang W; Hu B; Fallon MB
J Gastroenterol Hepatol; 2016 Nov; 31(11):1888-1894. PubMed ID: 27029414
[TBL] [Abstract][Full Text] [Related]
6. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
[TBL] [Abstract][Full Text] [Related]
7. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
Yang W; Zhang J; Hu B; Wu W; Venter J; Alpini G; Fallon MB
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G72-80. PubMed ID: 24200956
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung.
Chang CC; Wang SS; Hsieh HG; Lee WS; Chuang CL; Lin HC; Lee FY; Lee SD; Huang HC
Clin Sci (Lond); 2015 Sep; 129(6):449-60. PubMed ID: 25940601
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 activation of the endothelin B receptor modulates pulmonary endothelial CX3CL1 and contributes to pulmonary angiogenesis in experimental hepatopulmonary syndrome.
Zhang J; Yang W; Hu B; Wu W; Fallon MB
Am J Pathol; 2014 Jun; 184(6):1706-14. PubMed ID: 24731444
[TBL] [Abstract][Full Text] [Related]
10. The lung in liver disease: old problem, new concepts.
Fallon MB; Zhang J
Trans Am Clin Climatol Assoc; 2013; 124():250-62. PubMed ID: 23874031
[TBL] [Abstract][Full Text] [Related]
11. CXCR2 is involved in pulmonary intravascular macrophage accumulation and angiogenesis in a rat model of hepatopulmonary syndrome.
Li X; Chen Y; Chang Y; Li S; Zhao Z; Zhang H
Clin Sci (Lond); 2017 Jan; 131(2):159-168. PubMed ID: 27879294
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of lung injury induced by common bile duct ligation in mice.
Shikata F; Sakaue T; Nakashiro K; Okazaki M; Kurata M; Okamura T; Okura M; Ryugo M; Nakamura Y; Yasugi T; Higashiyama S; Izutani H
PLoS One; 2014; 9(4):e94550. PubMed ID: 24733017
[TBL] [Abstract][Full Text] [Related]
13. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome.
Zhang J; Ling Y; Luo B; Tang L; Ryter SW; Stockard CR; Grizzle WE; Fallon MB
Gastroenterology; 2003 Nov; 125(5):1441-51. PubMed ID: 14598260
[TBL] [Abstract][Full Text] [Related]
14. AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs.
Shen CC; Chen B; Gu JT; Ning JL; Zeng J; Yi B; Lu KZ
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):676-684. PubMed ID: 29233725
[TBL] [Abstract][Full Text] [Related]
15. Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
Li X; Chen Y; Wang L; Shang G; Zhang C; Zhao Z; Zhang H; Liu A
Braz J Med Biol Res; 2016 Jul; 49(7):. PubMed ID: 27383124
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis.
Li TH; Lee PC; Lee KC; Hsieh YC; Tsai CY; Yang YY; Huang SF; Tsai TH; Hsieh SL; Hou MC; Lin HC; Lee SD
Sci Rep; 2016 Dec; 6():39405. PubMed ID: 28009008
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.
Chang CC; Chuang CL; Lee FY; Wang SS; Lin HC; Huang HC; Teng TH; Hsu SJ; Hsieh HG; Lee SD
Clin Sci (Lond); 2013 Apr; 124(7):457-66. PubMed ID: 23043394
[TBL] [Abstract][Full Text] [Related]
18. Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.
Zhang HY; Han DW; Su AR; Zhang LT; Zhao ZF; Ji JQ; Li BH; Ji C
World J Gastroenterol; 2007 Dec; 13(47):6385-95. PubMed ID: 18081228
[TBL] [Abstract][Full Text] [Related]
19. Melatonin effects on pulmonary tissue in the experimental model of Hepatopulmonary Syndrome.
Bosco AD; Schedler FB; Colares JR; Schemitt EG; Hartmann RM; Forgiarini Junior LA; Dias AS; Marroni NP
J Bras Pneumol; 2019 May; 45(3):e20170164. PubMed ID: 31166552
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 promotes pulmonary intravascular macrophage accumulation by exacerbating BMP signaling in rat experimental hepatopulmonary syndrome.
Liu C; Gao J; Chen B; Chen L; Belguise K; Yu W; Lu K; Wang X; Yi B
Biochem Pharmacol; 2017 Aug; 138():205-215. PubMed ID: 28642034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
